Article Information
History
- June 9, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Emadeldin Hassanin1,
- Patrick May2,
- Rana Aldisi1,
- Isabel Spier3,4,
- Andreas J. Forstner3,5,6,
- Markus M. Nöthen3,
- Stefan Aretz3,4,
- Peter Krawitz1,
- Dheeraj Reddy Bobbili2,* and
- Carlo Maj1,*,#
- 1Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Bonn, Germany
- 2Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg
- 3Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany
- 4National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Germany
- 5Centre for Human Genetics, University of Marburg, Marburg, Germany
- 6Institute of Neuroscience and Medicine (INM-1), Research Center Jülich, Jülich, Germany
- ↵#Correspondence to Carlo Maj PhD. email: cmaj{at}uni-bonn.de
↵* Equal contribution,
These authors contributed equally: Dheeraj Reddy Bobbili, Carlo Maj
Posted June 09, 2021.
Breast and prostate cancer risk: the interplay of polygenic risk, high-impact monogenic variants, and family history
